As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Announcement: COVID-19 impact on peer review
Call For Papers
- Coronaviruses: emerging and re-emerging pathogens in humans and animals
- Bacteriophage Ecology and Evolution
- Bacteriophage based technologies for veterinary applications
- Contribution of climate change to the spread of infectious diseases
This thematic series emphasizes advances and key discoveries in the animal origin, viral evolution, epidemiology, diagnostics and pathogenesis of different emerging and re-emerging coronaviruses.
Edited by Susanna K. P. Lau and Siddharth Sridhar
A series focusing on phage population and community ecology, phage-host interaction, and integrated genomics and post-genomics approaches in microbial ecology are welcome.
Edited by Hugo Oliveira and Joana Azeredo
A series focusing phage therapy, antimicrobial phage enzymes, phage vaccines, phage diagnosis tools for veterinary applications are welcome.
Edited by Ana Oliveira and Joana Azeredo
This cross-journal collection brings together in one place articles outlining those diseases (and their vectors) that are likely to spread or are already spreading across borders due to the effects of climate change.
Sign up to receive article alerts
Virology Journal is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.
SARS-CoV-2 and COVID-19
Find a selection of articles published across Springer Nature, as well as additional commentary and books relevant to SARS-CoV-2 and COVID-19 research.Read more
Aims and scope
Virology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies.
Emerging viruses: Tom Geisbert, University of Texas Medical Branch, USA
Hepatitis viruses: Alan McLachlan, University of Illinois at Chicago, USA
Herpes viruses: Blossom Damania, University of North Carolina at Chapel Hill, USA
Influenza viruses: Hualan Chen, Chinese Academy of Agricultural Sciences, China
Negative-strand RNA viruses: Bert Rima, Queen’s University Belfast, UK
Other viruses: Erna Geessien Kroon, Universidade Federal de Minas Gerais, Brazil
Plant viruses: Chikara Masuta, Hokkaido University, Japan
Positive-strand RNA viruses: Alexander A Khromykh, University of Queensland, Australia
Retroviruses: Li Wu, Ohio State University, USA
Veterinary DNA viruses: Klaus Osterrieder, Freie Universität Berlin, Germany
Veterinary RNA viruses: Siba Samal, University of Maryland, USA
Viruses of microbes: Joana Azeredo, University of Minho, Portugal
Linfa Wang, Editor-in-Chief
Prof Wang is the director of the Programme in Emerging Infectious Diseases at Duke-NUS Medical School, and an honorary professor at the University of Melbourne and the Chinese Academy of Sciences. He is an international leader in the field of emerging zoonotic viruses and virus-host interaction, specialising in bat-borne viruses. After completing his Bachelor's degree in 1982 at the East China Normal University, he went on to obtain his PhD at the University of California, Davis. In 1990, he joined the CSIRO, Australian Animal Health Laboratory where he played a leading role in identifying bats as the natural host of the Severe Acute Respiratory Syndrome (SARS) virus.
Prof Wang's work has been recognized internationally through various international awards, numerous invited speeches at major international conferences, many top scientific publications, five patents and many invited book chapters. He holds a number of honorary positions and memberships and has received numerous awards such as the 2014 Eureka Prize for Research in Infectious Diseases. In 2010, Prof Wang was elected as a Fellow of Australian Academy of Technological Sciences and Engineering in recognition of his expertise in new and emerging diseases.
Annual Journal Metrics
64 days to first decision for reviewed manuscripts only
48 days to first decision for all manuscripts
122 days from submission to acceptance
21 days from acceptance to publication
2.464 - 2-year Impact Factor
2.468 - 5-year Impact Factor
0.954 - Source Normalized Impact per Paper (SNIP)
1.042 - SCImago Journal Rank (SJR)
595 Altmetric mentions